Tag:
Arcapta
Latest Headlines
Latest Headlines
FDA gives OK to Novartis' Arcapta
The FDA has approved Novartis' once-daily Arcapta Neohaler (indacaterol inhalation powder) 75 mcg for the long-term maintenance bronchodilator treatment of airflow obstruction in patients with COPD.
